Innovation and access: Improving Europe’s pharmaceutical regulatory framework
January 18, 2022
EMA “lags behind” other international regulators when it comes to approval timelines, finds EFPIA analysis.
Only a regulatory framework that “embraces a culture of excellence and innovation” will make Europe a world leader in life sciences and ensure people can reap the benefits of life-changing new treatments.
Read the source article at pharmaphorum.com
2022-01-13 13:23:21